My name is Todd Tushla, I'm the Vice President of Investor Relations at Neurocrine Biosciences. And on behalf of our entire company, welcome to our 2025 R&D Day, whether you're here in person, on the ...
Background In 2024, the UK National Institute of Health and Care Excellence (NICE) recommended TriageHF alerts as an option ...
Background In December 2022, California prohibited the sale of most flavoured tobacco products; however, limited data are ...